London +4420 814 42225
Moscow +7495 543 9194
Kiev +38044 599 2950

Our Clients

Order Informer

Home > News >

DSM announces two key management changes

September 24/2010

(DSM) -- Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces two key management changes.


Mr. Anton Robek (1959), most recently President and CEO of DSM Melamine, will be appointed as Senior Vice President of DSMs Emerging Business Area (EBA) DSM Bio-based Products & Services with effect from 1 January 2011. In this role he will build on the success of this EBA, formerly named DSM White Biotechnology, and drive its further commercialization as outlined in the strategy: DSM in motion: driving focused growth. Anton Robek will report to Mr. Rob van Leen, DSMs Chief Innovation Officer.


Mr. Volkert Claassen (1953), currently Vice President DSM White Biotechnology, has been appointed Vice President Strategy & Growth Options of the DSM Innovation Center and Vice President Strategy & Partnerships of DSM Bio-based Products & Services. Volkert Claassen has very successfully built the EBA DSM White Biotechnology into a launching platform for products and services in the areas of biofuels and biochemicals. His track record and extensive network in the biotechnology industry give DSM an excellent position to take this enlarged EBA to the next level.

DSM announces two key management changes











Category:General News
| More

Leave a comment

MRC help


 All News   News subscribe